Thanks for reading Scientific American. Create your free account or Sign in to continue. See Subscription Options. Recent Articles by Brendan Borrell The Most Exciting Moment of My Scientific Career Massachusetts pushes waste-based biofuels, holds off on corn, algae, and switchgrass Purported dodeca-mom delusional, probably not pregnant, authorities say.
Get smart. Sign up for our email newsletter. Sign Up. Read More Previous. Support science journalism. Knowledge awaits. This plant, which will include four litre bioreactors, will provide substantial additional capacity to support the growth of the two products. The company anticipates starting qualification runs next year and receiving regulatory approval for the production of Fabrazyme in and for the production of Cerezyme in Virus stops production at Genzyme's Allston Landing plant Aug Related Content.
Genzyme collaborates with Ablynx on multiple sclerosis project. New NCEs focus on cancer and orphan diseases. Meeting regulatory expectations. Genzyme and Alnylam expand rare genetic diseases collaboration. Anyone you share the following link with will be able to read this content:. Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Advanced search. Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.
Skip to main content Thank you for visiting nature. Download PDF. Authors Victor Bethencourt View author publications. Rights and permissions Reprints and Permissions. About this article Cite this article Bethencourt, V. Copy to clipboard. Efimova Antonina G.
Mukhamedzhanova Olga N. Ilinskaya BioNanoScience Viral contamination in biologic manufacture and implications for emerging therapies Paul W.
0コメント